Terry Ann Burrell Beam Therapeutics Inc. (BEAM) insider trading activity

BEAM Quotes by TradingView

Terry Ann Burrell is Chief Financial Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 82,637 shares of BEAM, which is worth approximately $2.07 Million. The most recent transaction as insider was on Sep 18, 2020, when has been sold 7,309 shares (Common Stock) at a price of $13.68 per share, resulting in proceeds of $99,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82.6K
0% 3M change
75.39% 12M change
Total Value Held $2.07 Million

Terry-Ann Burrell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 18 2020
BUY
Exercise of conversion of derivative security
$99,987 $13.68 p/Share
7,309 Added 50.0%
7,309 Common Stock

Also insider at

RXRX
RECURSION PHARMACEUTICALS, INC. Healthcare
Director
TB

Terry Ann Burrell

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on BEAM

Follow Beam Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

News

Receive news related to Beam Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BEAM